A rising trend in hospitalization for HTNE, with an overall decrease in in-hospital mortality was observed from 2002 to 2012, possibly related to changes in coding practices and improved management. Presence of acute cardiorespiratory failure, stroke/TIA, chest pain, and aortic dissection were most predictive of higher hospital mortality.
Original article
Hypertension is an important modifiable risk factor for cardiovascular disease. In the United States, nearly 1 out of 3 adults have elevated blood pressure, with the highest rates among African Americans. Within adults with hypertension, 82% are aware of their disease and only 53% have their blood pressure controlled to target levels. 1, 2 Hypertension remains the commonest encountered problem in primary care and is the most important modifiable risk factor when it comes to prevention of myocardial infarction, stroke, and renal failure. 3 A majority of patients with severely elevated blood pressure (blood pressure ≥ 180/120 mm Hg) have no evidence of end-organ damage and do not require immediate work up and aggressive treatment. 4 These patients with severe asymptomatic hypertension comprise 5% of emergency department visits and can be managed with oral antihypertensive medications, usually as outpatients. 5 Hypertensive emergency (HTNE) or acute severe hypertension previously known as malignant hypertension is characterized by an accelerated increase in blood pressure secondary to increase in catecholamines, sympathetic nervous system activity, endothelial dysfunction, renin-angiotensin system activation, or acute stress and is linked with acute end-organ damage. 6 Evidence of cardiac injury or infarction, pulmonary
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BACKGROUND
There are no comprehensive guidelines on management of hypertensive emergency (HTNE) and complications. Despite advances in antihypertensive medications HTNE is accompanied with significant morbidity and mortality.
METHODS
We queried the 2002-2012 nationwide inpatient sample database to identify patients with HTNE. Trends in incidence of HTNE and in-hospital mortality were analyzed. Logistic regression analysis was used to assess the relationship between end-organ complications and in-hospital mortality.
RESULTS
Between 2002 and 2012, 129,914 admissions were included. Six hundred and thirty (0.48%) patients died during their hospital stay. There was an increase in the number of HTNE admissions (9,511-15,479; P trend < 0.001) with concurrent reduction of in-hospital mortality (0.8-0.3%; P trend < 0.001) by the year 2012 compared to 2002. Patients who died during hospitalization were older, had longer length of stay, higher cost of stay, more comorbidities, and higher risk scores. Presence of acute cardiorespiratory failure [adjusted odds ratio (OR), 15.8; 95% confidence interval (CI), 13.2-18.9], stroke or transient ischemia attack (TIA) (adjusted OR, 7.9; 95% CI, 6.3-9.9), chest pain (adjusted OR, 5.9; 95% CI, 4.4-7.7), stroke/TIA (adjusted OR, 5.9; 95% CI, 4.5-7.7), and aortic dissection (adjusted OR, 5.9; 95% CI, 2.8-12.4) were most predictive of higher in-hospital mortality in addition to factors such as age, aortic dissection, acute myocardial infarction, acute renal failure, and presence of neurological symptoms.
edema, acute renal failure, stroke, and/or aortic dissection in the setting of acute rise in blood pressure are considered as end-organ damage. 7 Fortunately, the reported incidence of HTNE is 1 to 2 cases per million per year.
Approximately 1% of patients with known hypertension develop HTNE during their lifetime and a majority of HTNE cases are considered secondary to inadequate treatment. 8 In a case series of 100 patients admitted for HTNE, 50% of the patients with pre-existing hypertension had stopped taking their antihypertensive medications more than a month prior to admission. 9 A nationwide study in Italy showed that 8% of visits for HTNE had no prior documentation of hypertension. 10 With the advent of safe and improved antihypertensive therapies, outcomes among HTNE have shown improvement in recent years; however, there is still significant morbidity attached to disease. 11 Patients with HTNE remain at a higher short and intermediate term risk for mortality after adjusting for age, sex, and ethnicity among hypertensives. 12 Despite expansion in available antihypertensive treatment options, HTNE is still a clinical challenge and the disease remains prevalent. 13 In addition, there are currently no comprehensive evidencebased guidelines available for HTNE. Thus, there is marked variability in how it is treated. 14 The goal our study was to examine to temporal trends in incidence of HTNE and in-hospital mortality between the years of 2002-2012. We also assessed the relationship between specific acute end-organ damage and in-hospital mortality.
METHODS

Data source and study population
The Nationwide Inpatient Sample (NIS) is the largest, publicly available, all-payer inpatient database in the United States. Annually, the NIS is composed of discharge-level data from roughly 8 16 , missing data, and those transferred out of hospital were excluded from the study. Death was defined in the NIS as in-hospital mortality. Different comorbidities were identified by using ICD-9CM diagnoses and diagnosisrelated group (see Supplementary Appendix). In patients with HTNE, we assessed the prevalence of demographic factors, comorbidities (diabetes, coronary artery disease, chronic pulmonary disease, peripheral vascular disease, and secondary hypertension), length of stay, hospital charges, All Patient Refined Diagnosis Related Groups (APRDRG) subclasses for mortality and severity of illness risk score, procedures such as echocardiography, coronary revascularization [either percutaneous coronary intervention or bypass surgery (CABG)], and acute end-organ complications/symptoms associated with HTNE [acute myocardial infarction, aortic dissection, acute chest pain, acute renal failure, acute heart failure including acute pulmonary edema, acute neurological symptoms (hypertensive encephalopathy, confusion, altered mental status), and stroke or transient ischemic attack (TIA)]. We defined severity of comorbid conditions using Deyo modification of Charlson comorbidity index (CCI). This index contains 17 comorbid conditions with differential weights. The score ranges from 0 to 33, with higher scores corresponding to greater burden of comorbid diseases. Our primary outcome was in-hospital mortality and comparisons were made between those who survived to those with in-hospital death on the basis of above-mentioned variables.
Procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Helsinki Declaration of 1975 (as revised in 1983). Study was exempt from institutional board review at our institute.
Statistics
Demographics and baseline characteristics were summarized using descriptive statistics. Continuous data was expressed as mean ± 1 SD and analyzed using the student's t-test. Fischer's exact test or Pearson's chi-square test was used for analysis of categorical variables. Trend analysis was performed using the Mantel-Haenszel test and the analysis of variance test for categorical and continuous variables, respectively. A multivariable hierarchical mixed effect logistic regression model was created to evaluate the relationship between baseline demographics (age, African American race, sex), acute end-organ complications (acute myocardial infarction, acute renal failure, acute cardiorespiratory failure, stroke or TIA, aortic dissection, acute chest pain, neurological symptoms), and in-hospital mortality. Results were considered statistically significant for P values <0.05. IBM SPSS statistics version 20.0 (Armonk, NY) was used to perform data analysis.
RESULTS
Trends in admissions and mortality
A total of 129,914 admissions for HTNE were included from the year 2002 to 2012. There were 630 patient deaths during hospital stay (P trend < 0.05 for both trends). Figure 1 shows the annual trends in admissions and in-hospital for HTNE. There was a 63% increase in the number of admissions from 2002 to 2012 (9,511 to 15,479 admissions). On the other hand, the number of in-hospital mortality among HTNE admissions decreased from 0.8% per year in 2002 to 0.3% per year by 2012. By the year 2007, there was a 50% relative reduction in rate of mortality which was sustained thereafter. We also compared mortality rates monthly, which did not show any statistical difference (P = 0.43).
Additionally, we analyzed the annual trends in APRDRG subclasses for mortality and severity of illness risk score ≥3 in addition to the CCI. We found that there was a statistically significant uptrend in the proportion of patients with the higher grades of APRDRG subclasses for mortality risk ≥3 
Baseline characteristics
Patients were older (67.9 ± 16.6 years vs. 58.9 ± 17.1 years; P < 0.001) within the group that experienced in-hospital mortality compared to those who were alive at discharge. Most of the patients were admitted to urban nonteaching hospitals and regional variations in HTNE admissions were seen throughout the duration of the study with a consistently larger proportion of admissions being from the South (52.3%). Table 1 represents the baseline differences between patients who experienced in-hospital mortality and those who survived. Similar to age, the length of stay (11.7 days vs. 3.8 days; P < 0.001), and hospital charges ($88,899 vs. $23,701; P < 0.001) were significantly higher within the former group. Among those who experienced in-hospital mortality, a greater proportion of patients had peripheral arterial disease (19% vs. 9.8%; P < 0.001), chronic pulmonary disease (22% vs. 15.1%; P < 0.001), APRDRG mortality risk score, APRDRG severity score, number of baseline chronic conditions (7.9 ± 2.9 vs. 5.8 ± 2.7; P < 0.001), and CCI (3.6 ± 2.0 vs. 2. 0 ± 1.8; P < 0.001). Both the study groups were similar when it came to race or gender, weekend admission rate, and comorbidities such as diabetes, coronary artery disease, and secondary hypertension.
When we studied baseline socioeconomic status, we noticed that patients within the lowest income quartile for ZIP code had highest admission rate. Patients in the lowest 25 th percentile for income accounted for nearly 37% of total admissions, but experienced a similar in-hospital mortality rate compared to rest of the population (0.47% vs. 0.49%; P = 0.53). Forty-nine percent of all admitted patients had Medicare as primary insurer.
Procedures
The use of echocardiogram was higher in patients who died than survived (7.0% vs. 3.8%; P < 0.001). There was no significant difference in the use of coronary angiogram in the 2 groups (5.9% vs. 5.0%; P = 0.33); however, a higher proportion of patients received revascularization within the group with in-hospital death (2.2% vs. 0.5%; P < 0.001).
Outcomes and association with acute end-organ complications
The incidence of all studied acute end-organ complications was consistently higher within the group with inhospital mortality (Figure 2) . Patients who died were more than 7 times as likely to suffer from acute cardiorespiratory failure compared to the patients who survived (66.2 vs. 8.9; P < 0.001). Single-organ damage was reported in 85.7% of the patients who died compared to 28.6% in the group that survived. More than half (56.5%) of the patients within the former group had 2 or more reported end-organ complications.
Using multivariate logistic regression analysis (Table 2) , end-organ related complications such as acute cardiorespiratory failure [adjusted odds ratio (OR), 15.8; 95% confidence interval (CI), 13.2-18.9], stroke or TIA (adjusted OR, 7.9; 95% CI, 6.3-9.9), chest pain (adjusted OR, 5.9; 95% CI, 4.4-7.7), aortic dissection (adjusted OR, 5.9; 95% CI, 2.8-12.4) were most predictive of higher in-hospital mortality. Among other risk factors, acute myocardial infarction, acute renal failure, presence of neurological symptoms, and age were also predictive of higher mortality. Sex and African American race were not predictive of in-hospital mortality (P > 0.05).
DISCUSSION
The primary finding of this manuscript was that in a large multi-institutional observational cohort within the United States, there was a consistent increase in HTNE admissions with marked reduction of in-hospital mortality from 2002 to 2012. Within the in-hospital mortality group were older, had longer hospital stays, higher cost of stay, more tests/procedures, and a higher overall prevalence of baseline comorbidities such as peripheral arterial disease, chronic pulmonary disease, and clinical risk scores. Presence of acute cardiorespiratory failure, stroke/TIA, acute chest pain, aortic dissection, acute myocardial infarction, acute renal failure, neurological symptoms, and older age were all significantly predictive of higher in-hospital mortality. Patients who met the primary endpoint of in-hospital death had a significantly higher rate of end-organ complications, with almost 86% of the patients experiencing at least single-organ complications.
A study by Polgreen et al. examined the rising trend for more severe hypertension-related diagnoses following 2007 within NIS, and hypothesized that there was a substantial shift in the assigning of more severe diagnoses, less mild diagnoses, likely upcoding, and changes in billing practices. 15 Alterations in coding practices have also been described in other studies, some of which are influenced by reimbursement practices, and payment policies put forward by the Centers for Medicare and Medicaid Services. 16, 17 There was a trend toward increase in baseline comorbidity and risk scores during the same period among the HTNE patients in our study. We propose that finding may be in part secondary to upcoding of diagnoses, but improvements in care during this period are also likely to have played significant role in the decreased mortality.
A recent study on HTNE patients reported a mortality rate of 4.6%, much higher than reported in our study. 18 However, they exclusively analyzed patients admitted to the coronary care unit, thus inducing a selection bias and including patients requiring critical inpatient care and had a sample size of only 538 HTNE patients. Overall rate of inhospital mortality in our study was more comparable to the mortality rates seen with hypertensive urgency of 0.8% (126 patients) in the same study. A US registry consisting of 1,588 patients admitted with acute severe hypertension requiring intravenous antihypertensives found patients to have an even higher hospital mortality of 6.9%. 11 When we separately analyzed in-hospital mortality among our patients who had one or more of the studied complications, in-hospital mortality rate was 1.4%. The relatively lower mortality rates (with reduction in mortality trends) were likely due to the assignment of a diagnosis of HTNE among patients with lesser degrees of hypertensive disease with relatively benign presentation explained above. This can been seen in the relatively lower rate of end-organ damage in the group that survived within our study, with acute renal failure being reported in half of those. The study by Leiba et al. analyzed 1-year HTNE mortality rates at a large scale referral center in Israel over the course of 20 years and found a significant reduction in mortality rates during this time, which may be attributed to increased awareness of the worse outcomes associated with true diagnosis leading to prompt, efficient, and improved antihypertensive care. 19 Interestingly, they reviewed 306 patient files as part of their study and found that only 46% of the cases had a true diagnosis.
To date, large scale data on specific predictors for mortality in HTNE patients is missing. HTNE has been shown to have variable presentations when it comes to end-organ involvement. According to one 1996 study, cerebral infarction or hemorrhage (28.5%), acute pulmonary edema (23%), and hypertensive encephalopathy (16%) were the commonest types of end-organ damage. 11 Pacheco et al. found acute coronary syndrome (59.5%) and acute decompensated heart failure (25.2%) to be predominant in their assessment of coronary care unit patients. 10 Another study followed 297 HTNE patients for a median of 30 months and found that diabetes mellitus, acute left ventricular failure, stroke, and renal impairment were independent predictors of mortality. 20 In our study, we identified age, acute cardiorespiratory failure, acute renal failure, acute myocardial infarction, acute stroke or TIA, aortic dissection, and the presence of hypertensive neurologic symptoms or acute chest pain as independent factors affecting mortality. We did not find any significant gender-based variation in mortality, though has been reported in prior published literature. Among patients who died, 66.2% had acute heart failure, followed by renal failure (41.4%), neurological symptoms (21.3%), stroke/TIA (19.2%), and acute myocardial infarction (16.7%). Not all HTNE is created equal. Patients developing acute cardiorespiratory failure, stroke or TIA, and aortic dissection suffering from the worst outcomes.
Additional prognostic information was also obtained by using risk scores within the NIS database. APRDRG is a classification system that classifies patients according to their reason of admission, severity of illness, and risk of mortality and has been validated when it comes to predicting hospital outcomes. 21 Patients with in-hospital mortality were more likely to have a greater proportion of patients in the more severe subclasses for both risk scores. Patient with in-hospital mortality also had a higher CCI, a known prognostic marker for higher hospital mortality among other factors. 22 The incidence and mortality related to several cardiovascular emergencies especially myocardial infarction has a clear tendency to increase during the winter months. 23, 24 Deshmukh et al. analyzed the 2000-2007 NIS database and reported seasonal variations in the incidence of HTNE admissions, with a spike during the winter months. We analyzed the trends in seasonal mortality and found no significant difference in rates mortality throughout the year.
There are some limitations to this study. The study is based on administrative data. No charts were available and we did not study out of hospital deaths. We are heavily dependent on coders, which may have wide variation and potential for unrecognized miscoding. There is a possibility of selection bias and residual measured and unmeasured confounding factors, as this is a retrospective observational study. We were unable to assess beyond hospital stay or report upon treatment strategies used. We hope that the large number of database studied eliminates these limitations. We propose incremental improvement in care during the time of the study but are unable to evaluate the treatment strategies that may have been responsible. Our findings need validation in other large registries or observational studies, as it would enable us to risk stratify patients with HTNE and influence management. We strongly believe prospectively conducted studies with stringent criteria for diagnosis of HTNE are urgently needed to study the impact of end-organ complications and specific treatment strategies on outcomes.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of Hypertension online.
